We went past the sales page to see who sells GenF20 Plus, what its single clinical trial found, and how the refund policy really works.
Short answer: GenF20 Plus is no scam in the usual sense. Leading Edge Health, an established seller, stands behind it with a written 67-day guarantee. The catch is the evidence. Its single published trial found no significant IGF-1 rise over placebo once every participant was counted. The 28% figure on the sales page comes from a look at people over 40, made after the data were in, and growth hormone itself was never measured.
The seller is Leading Edge Health, which also puts out VigRX Plus, HyperGH 14x and many other products. According to the official site, Leading Edge Health Inc. has an office in Victoria, British Columbia, and Leading Edge Health Ltd. has one in Limassol, Cyprus. Payments run through LEM Processing LLC of Las Vegas, Nevada, a name that appears on sister sites. All of these addresses are public, and customers can reach support by toll-free phone or email.
The Better Business Bureau lists Leading Edge Health Inc. with an A+ rating and accreditation since August 2016. Still, the handful of public reviews there are negative, mainly over refunds and packages that never came. International shippers often draw complaints like these. Hold on to your receipts and tracking numbers.
So for the most basic question, the answer is yes: a real, established company sells a real product, and a box will show up. Whether the contents do what the marketing hints at is a separate matter.
The official site advertises that GenF20 Plus "increased IGF-1 levels by 28% after just 12 weeks." IGF-1 is made by the liver in response to growth hormone, which is why it sometimes serves as a stand-in. A real published trial lies behind the claim. The 28% figure, however, hides most of what the paper found.
| Detail | Details from the paper |
|---|---|
| Citation | Sonawane N, Kale V, Erande S, Chaudhary J. Open Access Journal of Clinical Trials, 2015; 7:35-42 |
| Design | Randomized, double-blind and placebo-controlled, at five outpatient centers in India |
| Who took part | Adults 35 to 65 with at least two of these: poor memory, low libido, low energy, poor sleep |
| Completed | 61 of the 70 randomized finished (31 GenF20 Plus, 30 placebo) |
| Dose and duration | Two tablets plus 2 mL of liquid under the tongue, twice a day, for 12 weeks |
| Main result, everyone included | IGF-1 went up 13.46 ng/mL with GenF20 Plus and 6.35 ng/mL with placebo. The gap was not statistically significant. |
| Source of the "28%" | A post hoc analysis of participants 40 and older, adjusted for differences at baseline |
| Other outcomes | Nothing significant versus placebo for body fat, lean mass, BMI, waist, memory, libido, energy or sleep |
| Funding | Carried out by Vedic Lifesciences and funded in part by DM Contact Management |
Counting all participants, the main outcome showed GenF20 Plus doing no better than placebo. A significant IGF-1 difference turned up only after the team sorted people by age once the trial was over. The age-40 cutoff came from the groups' mean and median ages, and the numbers were then adjusted because the two groups began at different IGF-1 levels. In the over-40 group, the raw comparison still wasn't significant.
Post hoc subgroup results can suggest what to test next, but they don't prove anything. Slice a small dataset enough ways and one slice may look "significant" by chance alone.
The authors didn't oversell it. They call the work a first exploratory study, say they did no sample size calculation, and describe the goal of 60 completers as "arbitrarily chosen." Their own words: the product "may not have delivered the projected efficacy results." What got measured was IGF-1, not growth hormone, and a footnote on the official site admits the study "did not measure for a direct increase in HGH." On everything else readers might want, including body composition, energy and sleep, GenF20 Plus and placebo looked alike.
Funding alone doesn't sink a study, but it's good to know. The paper reports no competing interests among the authors, while DM Contact Management paid for the trial. We couldn't independently verify how that company is linked to Leading Edge Health. Our closer look at the GenF20 Plus clinical evidence also covers the ingredient research.
PubMed doesn't list the GenF20 Plus trial, as far as we could tell. The paper ran in the Open Access Journal of Clinical Trials from Dove Medical Press, and the National Library of Medicine catalog shows that journal as not currently indexed for MEDLINE. The publisher calls the article peer reviewed and gives a registration number from India's clinical trials registry. Beyond this one trial, we found no other published study of GenF20 Plus and no independent replication.
The wider category has a track record too. Back in 2005, the Federal Trade Commission secured what it called the biggest monetary judgment in an FTC health fraud case, aimed at sellers of HGH pills and sprays (Leading Edge Health was not one of them). According to the FTC, it knew of no competent and reliable scientific evidence that such pills or sprays raise growth hormone levels or bring anti-aging benefits. Different products and a different year, yes, but that is the regulatory context for any "HGH releaser."
As of October 2026, the official guarantee page promises a refund if you try GenF20 Plus for 60 days (two boxes) and aren't satisfied. The fine print:
This is a genuine, written promise, and stronger than many competitors offer. One trap: the 67 days run from delivery, not from the day you open your first box. Planning on using the full 60 days means mailing the return early, with tracking. To keep the refund option, decide by about day 55 so returns arrive within 67 days of delivery. Nothing on the guarantee page covers purchases from other sellers, and we'd assume the company refunds only orders found in its own records.
| Green flags | Red flags |
|---|---|
| Established company with listed addresses and phone support | The headline "28%" claim comes from a post hoc subgroup |
| A published placebo-controlled trial of the actual product | Main result not significant; no other outcome beat placebo |
| Ingredient amounts for the tablets are on the site | The official site doesn't list the oral spray ingredients |
| A written 67-day guarantee | Tough terms: empty boxes, a firm deadline, no shipping refund |
| BBB accredited with an A+ rating | "No known side effects" contradicts its own trial data |
On the question of whether it's a scam, GenF20 Plus clears the bar: real company, real product, real guarantee, published trial. What the trial fails to show is that the product raises growth hormone or delivers what the sales page promises. It did not beat placebo on its main measure, the 28% result is a subgroup picked after the fact, and no other outcome improved over placebo.
Should you want to try it, treat it as a refundable experiment rather than a stand-in for medical care. Order from the official site, save your empty boxes and keep the 67-day deadline in view. Symptoms that you think are hormonal call for a doctor who can run tests. We give our overall verdict on cost and value in the full GenF20 Plus review.
Affiliate link: buying through it earns us a commission, and it costs you nothing extra. The 67-day money-back guarantee has conditions. Two opened, empty boxes and any unopened ones must reach the warehouse within 67 days of delivery. Shipping isn't refunded, duties and taxes must be paid before a refund, and each customer gets one refund.